PEOPLE: Startup Using AR To Help Those With Low Vision Adds Daniel Ting to Two of Its Boards. Ocutrx Said Ting Will Help With New Innovations…
A tech startup developing AR headsets has announced the appointment of Daniel Ting to the company’s international medical advisory board, as well as its newly-formed international scientific advisory board.
Ocutrx, with HQ in Irvine, manufactures the Oculenz AR headset for low-vision patients, and the AR ORLenz for surgeons, assistants, and interventional radiologist and telemedicine.
Ting will serve “as a critical voice and visionary for the company as Ocutrx moves forward with new innovations merging medical data, artificial intelligence (AI), and AR technologies for the healthcare space,” according to a press release issued by the company.
Medical data analytics and AI for surgeries are poised to become a major medical field; as data collected before, during and after surgeries has the potential to be critically analyzed for predictive database use in AR applications.
Ting is a global opinion leader, physician-surgeon and scientist-innovator who has already made contributions to developing global programs based on AI for ophthalmology, and, in particular, the retina.
As the Singapore National Eye Center clinical lead for AI in ophthalmology, Ting has received more than $1.5 million as the principal investigator and $25 million as co-investigator/collaborator research funding for his AI work.
More About Ocutrx
Ocutrx has its corporate HQ in Irvine, along with research, testing and development labs in Oklahoma and Colorado.
It makes lightweight AR headsets.
See recent article on Ocutrx here.